Plastic Injection Molding Machine for MedTech Market Size & Share 2025 - 2034

Plastic Injection Molding Machine for MedTech Market Size

The plastic injection molding machine for MedTech market size was estimated at USD 2.18 billion in 2024 and is projected to grow at a CAGR of 4.6% between 2025 and 2034. The rise in aging populations and the growing prevalence of chronic diseases in the U.S. and Europe are major structural drivers for the plastic injection molding market in MedTech packaging, as they are fuelling demand for high-volume, reliable, and safe medical devices, each requiring complex packaging components tailored for long-term care, chronic disease management, and elderly-friendly usage.

According to the data reported by U.S. Census Bureau, estimates from the 2022 Survey of Income and Program Participation (SIPP), over 30 million American adults having age between 18 and 64 were living with a disability. This number is expected to rise further. For instance, according to the same source, the population of Americans aged 65 and older is projected to more than double over the next four decades, reaching 80 million by 2040. Meanwhile, the number of adults aged 85 and above those most likely to require assistance with essential personal care is expected to nearly quadruple between 2000 and 2040.
 

According to the data reported by Eurostat, the EU’s median age has risen from 42.5 years in 2014 to 44.7 years by 2024. The population aged 80+ has grown from 3.8% in 2004 to 6.1% in 2024. Projections indicate that by 2050 nearly 30% of the EU will be aged 65 or older, with the old-age dependency ratio climbing toward 57%. This demographic expansion escalates the prevalence of long-term conditions such as diabetes, cardiovascular and respiratory diseases, and driving demand for daily-use medical devices. These devices in turn require precise, sterile, and ergonomic packaging, ideally produced through advanced plastic injection molding.
 

Plastic Injection Molding Machine for MedTech Market Trends

• The rapid expansion of emerging markets in the global medical device business is creating compelling current and future opportunities for the U.S. and Europe-based manufacturers of plastic injection molding machines, especially those supplying precision molding and packaging solutions to the MedTech sector. These opportunities are twofold: firstly, direct export growth to developing regions, and secondly, increased production and packaging demands from domestic MedTech OEMs that serve these expanding geographies.
   
• Demand surge in global medical device exports: The global rise in healthcare spending, particularly in Asia-Pacific, Latin America, Eastern Europe, and parts of the Middle East is catalyzing an unprecedented rise in the demand for affordable, high-quality medical devices. According to the U.S. International Trade Administration (ITA), the global medical device market is projected to reach USD 800 billion by 2030, with emerging markets contributing over 40% of this growth. European MedTech companies already export 60% of their production, with Germany, Ireland, and the Netherlands acting as central hubs for packaging and sterilization activities before international distribution. This export-heavy dynamic increases demand for high-throughput, validated injection molding systems that support cost-efficient, compliant, and scalable packaging lines. Manufacturers in the U.S. and Europe must now invest in injection molding machines that allow for rapid changeovers, multi-component capabilities, and integrated quality control systems tailored to varying international regulatory standards. As more Western MedTech OEMs target volume growth in low- and middle-income countries, plastic injection molding machine providers such as those offering cleanroom-compatible solutions are becoming essential to enabling this scale.
   
• Onshoring and Global Contract Manufacturing Expansion: Looking ahead, a strategic shift in global MedTech production dynamics is unfolding. To reduce supply chain vulnerabilities revealed during the COVID-19 pandemic, many U.S. and European MedTech firms are adopting regionalized manufacturing and packaging models, including the onshoring or nearshoring of plastic part production. These shifts are increasing capital investment in next-generation injection molding machines that support customized, small-batch runs, multi-material molding, and automated packaging integration, especially for single-use devices, diagnostic kits, and minimally invasive surgical tools. Moreover, as global healthcare regulations tighten, particularly in rapidly developing regions, U.S. and EU companies with GMP-certified, ISO 13485-aligned production systems will have a competitive edge. This positions local equipment manufacturers to benefit from an uptick in domestic and near-shore contract manufacturing, further driving machinery demand.
   

Plastic Injection Molding Machine for MedTech Market Analysis

Based on machine type, the market of plastic injection molding machine for MedTech is categorized into hydraulic machine, electric machine, hybrid machine, micro machine. The hydraulic segment accounted for revenue of around USD 891.6 million in 2024 and is estimated to grow at a CAGR of 3.9% from 2025 to 2034. 
 

• Hydraulic injection molding machines are still the platform of MedTech manufacturing. They offer high injection pressures and consistently high clamping force. High injection pressures are an advantage for molding complex biomedical components like IV connectors and syringe barrels. Hydraulic machines are built solid and provide consistent quality through large batch sizes. They also have high viscosity melting and hold on to it at high temperatures. Although they are energy inefficient machines typically associated with a high-power requirement, their durability and acclimation for heavy duty molds better suit a production line that requires dependability and necessary uptime. The more recent hydraulic machine controls include energy-efficient features and sensors that enhance provide consistency between mold heaters and heat times, which in turn reduce waste and save energy; however, they will not complete with Electric for energy efficiency and precise control because they are not allowed to compete with electric machines.

Learn more about the key segments shaping this market

Download Free PDF

The clamping force of the plastic injection molding machine for MedTech market consists of 0-200-ton force, 201-500 ton force, above 500-ton force. The 0-200-ton segment emerged as the leader and held 59.3% of the market  share in 2024 and is anticipated to grow at a CAGR of 5.1% from 2025 to 2034.
 

• Machine with 0-200 tons of clamping force are the predominant machines in the MedTech industry because they permit small-component manufacturing and precision components. Due to their small size, they are ideal for lightweight disposable items such as surgical instruments, catheter tips, dental devices, and microfluidic devices. For basic part designs, the machines run smaller cycle times, use less energy, and fit cleanroom environments. These are compounded by the machines' competitiveness for precision and high-volume production of critical devices. For most precision and/or volume applications, these machines have a cost advantage, in addition to projected lower energy costs, reduced roadway industrial footprint, and ease of integration into modular production platforms.
   

The application of the plastic injection molding machine for MedTech market consists of packaging, diagnostic, surgical, and others. The packaging segment emerged as the leader and held 55.6% of the market share in 2024 and is anticipated to grow at a CAGR of 5.2% from 2025 to 2034.
 

• Sterile Packaging Components: These packaging components are trays, pouches, blisters, and wrappers that help maintain an aseptic condition for medical devices including surgical instruments and implants. Aseptic packaging components must withstand either EO, gamma, or steam sterilization. A growing number of aseptic packaging components such as smart indicators and antimicrobial coatings, continue to drive improvements in safety, usability, and compliance with regulations.
   
• Caps and Closures; Closures and caps are found in pharmaceutical and diagnostic packaging where they securely seal the package. They are made from medical-grade polymers allowing for adequate chemical resistance and compatibility with sterilization. Integrating features such as tamper-evidence and RFID tags are areas where closures and caps are growing with demand for smart packaging and more sustainable products.
   
• Protective Packaging: Protective packaging is provided for expensive and fragile devices, and it includes custom trays, foams, and rigid containers identified to provide protection from impact, contamination, and environmental exposure. Sustainability trends will drive protective packaging to also utilize recyclable and/or biodegradable materials.
   
• Others: Others highlight specialty format packaging components such as unit-dose blisters, autoinjectors, and multi-compartment packaging systems for wearables, biosensors, and home diagnostics. Focus is on easy to use, accurate dosing, resealable and tamper-evident options, all contributing to the rising trend of home health care.

The U.S. dominates the overall North America plastic injection molding machine for MedTech market and valued at USD 518.9 Million in 2024 and is estimated to grow at a CAGR of 3.1% from 2025 to 2034.
 

• Hydraulic machines continue to be the preferred choice in traditional MedTech manufacturing plants within the U.S. because they are affordable and can machine complex parts with larger shot sizes. They find special preference with traditional contract manufacturers that deal in high-volume production of heavy-duty parts such as housing and trays. Increasingly, they are employed in the U.S. MedTech industry for energy efficiency, environmental cleanliness, and precision—more important particularly in the production of diagnostic components and surgical devices. U.S. SMEs and R&D laboratories appreciate electric machines for their noiseless operation, high cycle speeds, and low maintenance.
   

In the EU plastic injection molding machine for MedTech market, Germany is expected to experience significant and promising growth from 2025 to 2034.
 

• European hydraulic machines are being displaced by hybrid and electric machines on account of regulatory interest in power efficiency and precision. Micro machines are becoming popular with the emergence of minimally invasive surgical and diagnostic technologies, particularly in northern and Western Europe. Hot runner systems, servo Molds, and precision mold technology are extensively utilized as per MDR (Medical Device Regulation) and ISO 13485. Multi-cavity and stack Molds are essential for mass production of consumables, particularly in pharmacy packaging.
   

In the APAC plastic injection molding machine for MedTech market, China held 34.7% market share in 2024 and is anticipated to grow at a CAGR of 5.2% from 2025 to 2034.
 

• The plastic injection molding machine (PIMM) market in the MedTech segment in the Asia-Pacific (APAC) market is witnessing robust growth on the back of a confluence of local manufacturing expansion, home-country healthcare need, and strategic government initiatives. China, India, Singapore, and Malaysia have evolved as global hotspots for manufacturing medical devices, drawing both foreign multinationals and contract manufacturers with their cost benefit as well as talent base of trained manpower. Increased healthcare expenditure and big populations in these nations are driving demand for mass-produced medical devices like syringes, diagnostic equipment, and surgical disposables—driving investment in electric, hybrid, and micro injection moulding machines specifically designed for cleanroom and high-precision applications. Also driving machine uptake is government-supported incentives like India's PLI scheme and China's MedTech industrial clusters. Production of CE- and FDA-approved devices for export is also driving demand for energy-efficient and high-speed PIMMs.
   

The Middle East and Africa plastic injection molding machine for MedTech market, UAE and Saudi Arabia, is expected to experience significant and promising growth from 2025 to 2034.
 

• MEA region production is driven by increasing focus on developing healthcare infrastructure and medical independence. Saudi Arabia, UAE, Egypt, and South Africa are experiencing rapid growth in diagnostic centers, hospitals, and public health initiatives, hence local demand for disposable plastic medical devices. Post-pandemic realignment of policies has experienced added fervor for import independence, which has encouraged investment in small- and mid-range injection molding facilities to fuel local production. Foreign direct investment and joint ventures with MedTech companies, especially in the GCC nations, are also propelling adoption of quality molding systems meeting international standards like ISO 13485 and WHO GMP. Automation remains to gain prominence, but MEA markets increasingly use cost-efficient hydraulic and hybrid equipment to manufacture low-risk, simple medical disposables like IV connector and test kit parts.
   

Plastic Injection Molding Machine for MedTech Market Share

• The market leaders in the MedTech industry's plastic injection molding machine (PIMM) market—Engel, Arburg, KraussMaffei, Sumitomo (SHI) Demag, and Husky Injection Molding Systems—achieved their positions through leveraging technology leadership, medical application specialization, and solid global support strategies.
   
• Engel stands out by providing integrally complete and energy-efficient molding solutions that are specifically designed for cleanroom environments. Its hybrid and electric machines, like the e-motion line, are used extensively in MedTech production due to precision and hygiene. Engel's vertical integration model of not only supplying machines but also digital solutions and robots has made it a go-to one-stop-shop for medical OEMs. Arburg, in contrast, is renowned for micro-molding and modular machine construction. Its ALLROUNDER product portfolio is very flexible, wherein companies can easily downscale from implants of the size of micrometers to diagnostic components. Arburg also leads in Industry 4.0 preparation with its arburgXworld platform.
   
• KraussMaffei excels in high-complexity and multi-component molding procedures such as liquid silicone rubber (LSR) and thermoplastic elastomers (TPE), which are crucial to manufacturing flexible medical components. The firm provides comprehensive digital twin and automation integration solutions to optimize operations and traceability, critical for regulated applications. Sumitomo (SHI) Demag drives all-electric machines with unparalleled cycle speeds and outstanding repeatability—critical for high-volume production of disposable medical devices. Its emphasis on sustainability and accurate motion control are in keeping with the stringent needs of medical molding.
   
• Husky Injection Molding Systems leads in high-volume production of medical devices such as syringes and diagnostic tubes. Husky's strategy is built around providing turnkey systems—equipment, molds, hot runners, and automation—along with high-cavitation, high-speed solutions. Globally, these firms are differentiated on the basis of cleanroom compatibility, validation-ready systems, technical competency, and local infrastructure for service to be the go-to organization for MedTech
   

Plastic Injection Molding Machine for MedTech Market Companies

Major players operating in the plastic injection molding machine for MedTech industry include:

• Arburg
• Billion
• BOLE Machinery
• Chen Hsong Holdings Limited
• Engel
• Ferromatik Milacron
• Husky Injection Molding Systems
• JSW
• KraussMaffei
• Negri Bossi
• Nissei Plastic Industrial Co., Ltd.
• Netstal
• Sumitomo Demag
• Tederic Machinery
• Wittmann Battenfeld
• Battenfeld
   

The machine depth of a manufacturer's range is characterized by the machine model variety, tonnage capability, special medical molding capabilities (e.g., liquid silicone rubber [LSR] molding, micro-molding, multi-component injection), and cleanroom standard accommodation. Engel has the complete electric and hybrid machine range well optimized for diagnostic components and labware. Arburg has a specialty in micro-injection molding technology for minimally invasive medical devices. Sumitomo (SHI) Demag excels in high-precision and high-speed systems for syringe barrels, vials, and connectors. Husky, on the other hand, excels in preform and medical consumable production lines with in-house integrated hot runners and automation. These firms constantly develop their product portfolio to cover digital controls, energy saving, and conform to ISO 13485 and GMP standards. Depth of portfolio also encompasses system-level items such as integrated robotics and vision inspection.
 

Plastic Injection Molding Machine for MedTech Market News

• In March 2025, The Italian injection Molding specialist Sapa has announced the 100 percent acquisition of Megatech Industries. This also includes the German sites. Sapa aims to expand its leading position in the field of plastic injection Molding and to expand its international customer base and presence.
   
• In March 2025, Husky Technologies, the technology and solutions market leader in injection molding, made an announcement on acquiring MGS Healthcare Manufacturing's (MGS) secondary injection business and rotary platen technologies. This acquisition further establishes Husky as a supplier of complete multi-material solutions to key industries such as medical, packaging, and consumer electronics.
   
• In 2022, CoreTech System Co., Ltd. (Moldex3D) launched a strategic partnership with Sumitomo Heavy Industries, Ltd. (SHI) to close the gap between virtual CAE simulation and actual injection molding machines closer. The collaboration created a two-way bridge from CAE simulation to an actual injection molding machine. It not only shortens the time lag from design to production by embracing digital twin technology but also significantly reduces time to mass-production.
   

The plastic injection molding machine for MedTech market research report includes in-depth coverage of the industry, with estimates & forecast in terms of revenue (USD Million) and volume (Thousand Units) from 2021 to 2034, for the following segments:

Click here to Buy Section of this Report

Market, By Machine Type

• Hydraulic machines
• Electric machines
• Hybrid machines
• Micro machines

Market, By Technology

• Hot runner systems and cold runner systems
• Multi-cavity and family mold designs
• Stack mold technology
• Servo-actuated mold systems
• High-precision mold technologies

Market, By Clamping Force

• 0-200 Ton Force
• 201-500 Ton Force
• Above 500 Ton Force

Market, By Application

• Packaging
  • Sterile packaging components
  • Caps and closures
  • Protective packaging
  • Others
• Diagnostic
• Surgical
• Others

Market, By End Use

• B2B MedTech Companies
  • Large
  • SME
• Pharmaceutical and Combination Product Manufacturers
• Contract Manufacturing Organizations (CMOs)
• Research and Development Organizations
  • Medical Research Institutions
  • Medical Incubators and Innovation Centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia 
• Latin America
  • Brazil
  • Mexico 
• MEA
  • Saudi Arabia
  • UAE
  • South Africa